1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Colorectal Cancer Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Colorectal Cancer Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Colorectal Cancer Market Regional Analysis
6.2 Europe Colorectal Cancer Market Revenue 2020-2028 (US$ Million)
6.3 Europe Colorectal Cancer Market Forecast Analysis
7. Europe Colorectal Cancer Market Analysis – by Modality
7.1 Diagnosis Type
- 7.1.1 Overview
- 7.1.2 Diagnosis Type: Europe Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Therapy Type
- 7.2.1 Overview
- 7.2.2 Therapy Type: Europe Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Imaging Type
- 7.3.1 Overview
- 7.3.2 Imaging Type: Europe Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Europe Colorectal Cancer Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Diagnostic and Research Laboratories
- 8.2.1 Overview
- 8.2.2 Diagnostic and Research Laboratories: Europe Colorectal Cancer Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Europe Colorectal Cancer Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Colorectal Cancer Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 9.2.1.1 Europe Colorectal Cancer Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 UK: Europe Colorectal Cancer Market Breakdown, by Modality
- 9.2.1.1.2 UK: Europe Colorectal Cancer Market Breakdown, by End User
- 9.2.1.2 Germany:
Europe Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Germany: Europe Colorectal Cancer Market Breakdown, by Modality
- 9.2.1.2.2 Germany: Europe Colorectal Cancer Market Breakdown, by End User
- 9.2.1.3 France:
Europe Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 France: Europe Colorectal Cancer Market Breakdown, by Modality
- 9.2.1.3.2 France: Europe Colorectal Cancer Market Breakdown, by End User
- 9.2.1.4 Russia:
Europe Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Russia: Europe Colorectal Cancer Market Breakdown, by Modality
- 9.2.1.4.2 Russia: Europe Colorectal Cancer Market Breakdown, by End User
- 9.2.1.5 Italy:
Europe Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.5.1 Italy: Europe Colorectal Cancer Market Breakdown, by Modality
- 9.2.1.5.2 Italy: Europe Colorectal Cancer Market Breakdown, by End User
- 9.2.1.6 Rest of Europe:
Europe Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Colorectal Cancer Market Breakdown, by Modality
- 9.2.1.6.2 Rest of Europe: Europe Colorectal Cancer Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Abbott
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Amgen Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Bruker Corporation
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Clinical Genomics Technologies Pty Ltd.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Epigenomics AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 F. Hoffmann-La Roche AG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Quest Diagnostics
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 VolitionRx Limited
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Europe Colorectal Cancer Market
